EUVIMEDOpdag EUVIMED
CrossrefInfokort

Dual Kidney Transplantation Offers Prolonged Graft Survival

Ekaterina Fedorova, Sofia Nehring Firmino, David Foley, Jacqueline Garonzik‐Wang, Dixon Kaufman, Jon Odorico, David Aufhauser, Nikole A. Neidlinger, Carrie Thiessen, Jennifer Philip, Kelly M. Collins, Josh Mezrich, David Al‐Adra, Didier Mandelbrot, Brad C. Astor, Sandesh Parajuli

Clinical Transplantation · 2026-02 · 40 (2)

DOI: 10.1111/ctr.70481 ↗
AbstractBibliografiske oplysninger

Abstract

ABSTRACT Introduction Dual kidney transplantation (DKT), an uncommonly performed procedure, provides a unique opportunity to transplant nonstandard kidneys that might otherwise not be utilized. We compared perioperative and five‐year posttransplant outcomes between DKT, and single kidney transplants (SKT) performed at our institution. Methods We analyzed all adult deceased donor kidney‐alone transplant recipients at our center between 2001 and 2020. Recipients of pediatric en bloc kidney transplants were excluded. Perioperative outcomes of interest included delayed graft function (DGF), posttransplant length of stay (LOS), rehospitalization, and reoperation. Five‐year outcomes included biopsy‐proven acute rejection (AR), death‐censored graft failure (DCGF), uncensored graft failure (UCGF), and death with functioning graft (DWFG). Results A total of 100 DKT and 3125 SKT recipients were included. DKT recipients were older ( p < 0.001), more often male (68%), and more often underwent early steroid withdrawal ( p = 0.04). In comparison to SKT, after adjustment for multiple variables, DKT was not independently associated with DGF (aOR: 1.25; 95% CI 0.76–2.08); prolonged LOS (linear coefficient 0.42; −0.9–1.7); reoperation (aOR: 0.73; 95% CI: 0.21–2.51) or rehospitalization (aOR 0.98; 95% CI: 0.55–1.74). However, within five years, DKT had a lower adjusted incidence rate ratio (aIRR) for AR (aIRR: 0.28; CI 0.12–0.64); DCGF (aIRR: 0.30; 95% CI 0.13–0.68), and UCGF (aIRR: 0.53; 95% CI: 0.33–0.86), without statistically significant differences in DWFG (aIRR: 0.83; 95% CI: 0.46–1.53). Conclusion In selected recipients, DKT offered superior medium‐term outcomes compared to SKT without compromising perioperative outcomes. DKT can mitigate concerns associated with medically complex donor kidneys, increase organ utilization, and increase access to transplantation.

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.

Se priser →